Display options
Share it on

Front Psychiatry. 2010 Oct 12;1:134. doi: 10.3389/fpsyt.2010.00134. eCollection 2010.

Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI study.

Frontiers in psychiatry

David Pincus, Samet Kose, Ashley Arana, Kevin Johnson, Paul S Morgan, Jeffrey Borckardt, Tal Herbsman, Fran Hardaway, Mark S George, Jaak Panksepp, Ziad Nahas

Affiliations

  1. SUMMA Health, Akron OH, USA.

PMID: 21423444 PMCID: PMC3059627 DOI: 10.3389/fpsyt.2010.00134

Abstract

BACKGROUND: Oxytocin is a stress-attenuating and pro-social neuropeptide. To date, no study has looked at the effects of oxytocin in modulating brain activity in depressed individuals nor attempted to correlate this activity with attribution of mental activity in others.

METHOD: We enrolled 10 unmedicated depressed adults and 10 matched healthy controls in a crossover, double blind placebo controlled fMRI 40 i.u. intra-nasal oxytocin study (20 i.u. per nostril). Each subject performed reading the mind in the eyes task (RMET) before and after inhalation of oxytocin or placebo control for a total of 80 scans.

RESULTS: Before oxytocin administration, RMET engaged the medial and lateral prefrontal cortex, amygdala, insula and associative areas. Depressed subjects showed increased anterior ventral activation for the RMET minus gender identification contrast whereas matched controls showed increased dorsal and frontal activity. Compared to placebo, oxytocin in depressed subjects showed increased activity in the superior middle frontal gyrus and insula, while controls exhibited more activity in ventral regions. Oxytocin also led to inverse effects in reaction times on attribution task between groups, with controls getting faster and depressed individuals slower to respond.

CONCLUSION: Depression is associated with increased paralimbic activity during emotional mental attribution of others, appearing to be distinctly modulated by oxytocin when compared to healthy controls. Further studies are needed to explore long-term exposure to pro-social neuropeptides on mood in depressed populations and assess their clinical relevance.

Keywords: depression; fMRI; mentalization; oxytocin; theory of mind

References

  1. Psychoneuroendocrinology. 1998 Nov;23(8):819-35 - PubMed
  2. Child Dev. 2002 Nov-Dec;73(6):1715-26 - PubMed
  3. Psychopharmacology (Berl). 2010 Apr;209(3):225-32 - PubMed
  4. Ann N Y Acad Sci. 1993 Jul 22;689:250-68 - PubMed
  5. Biol Psychiatry. 1996 Sep 15;40(6):547-9 - PubMed
  6. Ann N Y Acad Sci. 2009 Apr;1159:86-105 - PubMed
  7. J Neurosci. 2010 Apr 7;30(14):4999-5007 - PubMed
  8. Biol Psychiatry. 2008 Jan 1;63(1):3-5 - PubMed
  9. J Affect Disord. 2007 Nov;103(1-3):29-42 - PubMed
  10. J Am Psychoanal Assoc. 2007 Spring;55(2):411-56 - PubMed
  11. Prog Brain Res. 1998;119:127-36 - PubMed
  12. J Child Psychol Psychiatry. 2001 Feb;42(2):241-51 - PubMed
  13. Adv Drug Deliv Rev. 1998 Jan 5;29(1-2):81-87 - PubMed
  14. Psychoneuroendocrinology. 2007 Jun;32(5):565-74 - PubMed
  15. J Consult Clin Psychol. 1993 Dec;61(6):941-51 - PubMed
  16. J Neurosci. 2007 Oct 24;27(43):11573-86 - PubMed
  17. Brain. 2001 Feb;124(Pt 2):279-86 - PubMed
  18. Psychol Aging. 1998 Mar;13(1):164-75 - PubMed
  19. Brain Cogn. 2006 Jun;61(1):122-30 - PubMed
  20. Conscious Cogn. 2005 Mar;14(1):30-80 - PubMed
  21. J Int Neuropsychol Soc. 2008 Jan;14(1):55-62 - PubMed
  22. J Affect Disord. 2007 Dec;104(1-3):1-14 - PubMed
  23. Neuropsychopharmacology. 2010 Jan;35(1):192-216 - PubMed
  24. Neurosci Biobehav Rev. 1998 May;22(3):437-52 - PubMed
  25. Biol Psychiatry. 2007 Mar 15;61(6):731-3 - PubMed
  26. Am J Psychiatry. 1999 May;156(5):675-82 - PubMed
  27. Neuroreport. 1996 Dec 20;8(1):197-201 - PubMed
  28. J Neurosci. 2005 Dec 7;25(49):11489-93 - PubMed
  29. Am J Psychiatry. 2008 Sep;165(9):1127-35 - PubMed
  30. Curr Opin Neurobiol. 2004 Apr;14(2):248-53 - PubMed
  31. Med Image Anal. 2001 Jun;5(2):143-56 - PubMed
  32. Hum Brain Mapp. 2002 Nov;17(3):143-55 - PubMed
  33. Horm Behav. 2005 Dec;48(5):522-7 - PubMed
  34. Curr Opin Neurobiol. 2008 Apr;18(2):179-84 - PubMed
  35. Schizophr Res. 2000 Apr 7;42(2):145-55 - PubMed
  36. Biol Psychiatry. 1996 Sep 15;40(6):559-60 - PubMed
  37. J Child Psychol Psychiatry. 2000 Nov;41(8):1049-56 - PubMed
  38. Neuroimage. 2001 Dec;14(6):1370-86 - PubMed
  39. J Autism Dev Disord. 2008 Oct;38(9):1731-9 - PubMed
  40. J Child Psychol Psychiatry. 1991 Nov;32(7):1081-105 - PubMed
  41. Neuropsychologia. 2000;38(1):11-21 - PubMed
  42. Neuroimage. 2002 Oct;17(2):825-41 - PubMed
  43. Child Abuse Negl. 2003 Apr;27(4):363-80 - PubMed
  44. J Autism Dev Disord. 1994 Apr;24(2):129-54 - PubMed
  45. J Psychopharmacol. 2006 Sep;20(5):656-60 - PubMed
  46. Eur J Neurosci. 2005 Sep;22(5):1221-32 - PubMed
  47. Neuroimage. 2001 Jul;14(1 Pt 1):170-81 - PubMed
  48. Emotion. 2003 Mar;3(1):97-105 - PubMed

Publication Types

Grant support